COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT00908180
Brief Title: Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

First Submitted : May 22, 2009
First Submitted that Met QC Criteria : May 22, 2009
First Posted : May 25, 2009 (Estimate)

Last Update Submitted that Met QC Criteria : August 1, 2013
Last Update Posted : August 2, 2013 (Estimate)